M. Olsen

3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies.

J. Dwyer, Z. Hughes, A. Gilbert, 2011, Bioorganic & medicinal chemistry letters.

WAY‐100635 antagonist‐induced plasticity of 5‐HT1A receptors: regulatory differences between a stable cell line and an in vivo native system

S. Nawoschik, J. Dunlop, Jean Y Zhang, 2006, Journal of neurochemistry.

Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell line.

S. Nawoschik, X. Khawaja, D. Smith, 2007, Journal of pharmacological and toxicological methods.

Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.

R. A. Hunt, Afshin Ghavami, K. Young, 2004, Cellular signalling.

ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

F. Liu, M. Day, T. Comery, 2008, Journal of Pharmacology and Experimental Therapeutics.

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

J. Brennan, J. Dwyer, R. Ring, 2013, Neuropharmacology.

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.

H. Kao, T. Branchek, R. Weinshank, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Cloning, mRNA localization and evolutionary conservation of a human 5-HT7 receptor pseudogene.

L. Schechter, M. Olsen, M. Olsen, 1999, Gene.

The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

H. Kao, T. Branchek, C. Gerald, 1995, The EMBO journal.

Site‐directed mutagenesis of a single residue changes the binding properties of the serotonin 5‐HT2 receptor from a human to a rat pharmacology

H. Kao, T. Branchek, R. Weinshank, 1992, FEBS letters.